KPIs & Operating Metrics(New)
Breakdown Of AssetsCost Of SalesEmployee StatisticsGross Margin %Gross Margin Annual %Gross ProfitGross Profit AnnualIncome Before Income TaxesNon Gaap ProfitabilityNon Gaap Profitability %Non Gaap Profitability AnnualNon Gaap Profitability Annual %Opex As A % Of Total Revenue %OPEX SegregationProperty, Plant And Equipment BreakdownRevenue By Business SegmentRevenue By Business Segment %Revenue By Business Segment AnnualRevenue By Business Segment Annual %Revenue By GeographyRevenue By Geography %Revenue By Geography AnnualRevenue By Geography Annual %Revenue By Product BiosimilarsRevenue By Product (Biosimilars) AnnualRevenue By Product CardiovascularRevenue By Product (Cardiovascular) AnnualRevenue By Product Non Opid Pain , Bone & DermatologyRevenue By Product (Non Opid Pain , Bone & Dermatology) AnnualRevenue By Product RespiratoryRevenue By Product (Respiratory) AnnualRevenue By Product Women'S HealthRevenue By Product (Women'S Health) Annual
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Organon (OGN) Gross Profit (2020 - 2025)

Organon has reported Gross Profit over the past 6 years, most recently at $741.0 million for Q4 2025.

  • Quarterly results put Gross Profit at $741.0 million for Q4 2025, down 17.3% from a year ago — trailing twelve months through Dec 2025 was $3.3 billion (down 10.82% YoY), and the annual figure for FY2025 was $3.3 billion, down 10.82%.
  • Gross Profit for Q4 2025 was $741.0 million at Organon, down from $857.0 million in the prior quarter.
  • Over the last five years, Gross Profit for OGN hit a ceiling of $1.0 billion in Q2 2021 and a floor of $741.0 million in Q4 2025.
  • Median Gross Profit over the past 5 years was $931.0 million (2024), compared with a mean of $928.9 million.
  • Biggest five-year swings in Gross Profit: decreased 26.33% in 2021 and later rose 9.95% in 2022.
  • Organon's Gross Profit stood at $1.0 billion in 2021, then fell by 11.25% to $891.0 million in 2022, then increased by 2.69% to $915.0 million in 2023, then fell by 2.08% to $896.0 million in 2024, then fell by 17.3% to $741.0 million in 2025.
  • The last three reported values for Gross Profit were $741.0 million (Q4 2025), $857.0 million (Q3 2025), and $874.0 million (Q2 2025) per Business Quant data.